Summary
ton~l-CoA carboxylase. Deficiency of 3-meth~lcroton~l-CoA Fibroblasts derived from a biopsy of the skin were grown in carboxylase was demonstrated in leukocytes from this patient culture in Eagle's minimal essential medium (MEM) with 10% (15) . A third patient reported (12) was not ketotic but re-fetal calf serum. Cells were harvested by trypsinization and lysed sponded to biotin.
by freezing and thawing three times in 0.05 M Tris-HCI at pH The second patient appeared to be unique in the occurrence of 8.0. Propionyl-CoA carboxylase was assayed by the incubation severe ketoacidosis and the fact that he was found to excrete of 5 x 106 cells (about 1 mg protein) in 1.5 ml at 30° for 30 min tiglylglycine (13, 14) . Tiglylglycine is a metabolite of isoleucine. in the presence of NaHI4CO,, and measurement of the fixation of It is excreted by patients with propionic acidemia (19) . There-CO, to propionyl-CoA as described by Tictz and Ochoa (25) , fore, we analyzed the urine of this patient in the search for the except for the addition of 50 mM KC1 to the assay (1 1). Unabnormal metabolites found in patients with propionic acidemia reacted H,l.'CO,, was by acidification with trichloroace- (3) . It is the purpose of this report to describe the identification tic acid and drying overnight under a heat lamp. Nonvolatile 14C
and quantitation of methylcitric acid and 3-hydroxypropionic incorporated in the presence of propionyl-CoA minus a cell acid in the urine. Enzyme assay of cultured fibroblasts demon-blank without propionyl-CoA represented product. Protein was strated a deficiency of propionyl-CoA carboxylase. A prelimi-determined by the biuret method (17) . nary report of these results has appeared in abstract form (23) .
A t the same time, Chalmerset al. (8) reported elevated amounts RESULTS of propionic and 3-methylcrotonic acid in urine from this patient. They also identified 3-hydroxypropionic acid and made a Typical liquid partition chromatograms for a normal subject tentative identification of methylcitric acid in the urine (9) .
and patient JR are shown in Figure 1 . The amounts of urine studied contained 1.0 mg creatinine. Retention times of acid peaks are expressed as R F values relative to citric acid which is equated to 100.0. The identities of the acids in all peaks were confirmed by comparison of M U values on G L C and the mass spectra of TMS derivatives of authentic standards. The major normal peaks in both urines were hippuric acid at R, 8.5-10.6, citric acid at R F 100.00, and isocitric acid at R, 102.9-103.0. In the urine o f J R the major elevated peak at R F 16.1 was 3-hydroxyisovalcric acid. The small peak at R F 17.6 in the normal was p-hydroxyphenylacetic acid, which also contributed to the R F 16.1 peak in patient JR. The peak at R F 12.2 in JR was 3-methylcrotonylglycine. The peak at 14.4 in the normal was acetic acid. The peak a t R F 61.8-63.9 in the normal contained trans-aconitic acid and pyrrolidone-2-carboxylic acid. A s shown in Figure 2 , the peak at R F 62.5 in J R also contained 3-hydroxypropionic acid. The double peaks at RF83.0 and 85.4 in J R were the erythro and thrco isomers of methylcitric acid. Figure 3 shows that the mass spectra of the TMS derivative of the R F 85.4 peak was identical to that of the tetra-TMS derivative of authentic methylcitric acid. The diastereoisomer at R F 83.0 had an identical mass spectra. N o methylcitric acid was detected in the normal subjects. Standard homocitric acid (3-carboxyl-3-hydroxyadipic acid) had an R F of 86.7 on liquid partition chromatography and the mass spectrum of the TMS derivative was very similar to that of methylcitric acid. However, the M U value for the TMS derivative of homocitric acid on G Table 1 . The excretion of 3-methylcrotonylglycine was 17-48 mg/day and that of 3-hydroxysiovalcric acid was 66-83 mg/day. The levcls of excretion of 3-hydroxypropionic acid were 1.6-4.0 mglday and that of methylcitric acid 3.7-5.8 mg/day .
These findings, along with evidence for decreased oxidation of ['4C]propionic acid to '"COz in fibroblasts derived from J R (2), strongly suggested a deficiency of propionyl-CoA carboxylase. Data on propionyl-CoA carboxylase activity in fibroblasts are shown in Table 2 . In J R the activity of this enzyme was 4 % of normal. This value was within the range of activity of cells from a series of four patients with propionic acidemia, in whom pro- pionyl-CoA carboxylase was defective. These assays were done with cells grown in MEM which contains no biotin except that contributed by the 10% fetal calf serum. Gompertz ct 01. (15) had previously shown a partial deficiency of 3-methylcrotonylCoA carboxylase in leukocytes from this patient. Furthermore, we have demonstrated deficiency of 3-methylcrotonyl-CoA carboxylase in fibroblasts (28) . Thus, the patient had deficient activity of two biotin-containing carboxylases.
DISCUSSION
This boy (JR) was the patient originally reported by Gompertz, Hull, and colleagues (14) under the designation of biotinresponsive /3-methylcrotonylglycinuria. It is important to distinguish this patient from the patient with biotin-responsive propionic acidemia also reported by Hull, Gompertz, and colleagues (6). J R had a remarkable therapeutic response to biotin. Nevertheless, the levels of excretion of 3-methylcrotonylglycine and 3-hydroxyisovaleric acid found in this study were appreciable while he was receiving 0.5 mg biotinlday. The amounts of 3-methylcrotonylglycine (17-48 mg/day) were less than those observed at 5 months of age when he was acutely ill and ketotic. At that time, excretion of 3-methylcrotonylglycine was 50-250 mgl day, whereas that of 3-hydroxyisovaleric acid was consistently less (14) . Following treatment at that time with 1 0 mg biotin/ day, these metabolites were not detectable (14) . A s the patient Fig. 3 . Mass spectra of trimethylsilyl derivatives of authentic methylcitric acid and methylcitric acid from RF 85.4 peak of patient JR. The spectra were obtained with an ionizing voltage of 70 eV. Relative intensities of ions are plotted against mass/charge (m/e) ratios. Only the fragments containing the major isotope of silicon are shown. Table 1 . Urinary excretion grew, the regimen of biotin treatment was sufficient to prevent illness but not sufficient to prevent the excretion of the abnormal products of leucine metabolism. It is of interest that considerably more 3-hydroxyisovaleric acid than 3-methylcrotonylglycine was excreted, the reverse of the situation when the patient was acutely ill.
The levels of excretion of 3-hydroxypropionie acid and methylcitric acid were in the lower range of those found in patients with propionic acidemia due to propionyl-CoA carboxylase deficiency (22, 26) . This is also consistent with an effect of biotin treatment. When the patient was acutely ill, he had excreted 100-150 mglday of tiglylglycine (14) . The absence of tiglylglycine in urine at the time of this study was consistent with the finding of relatively low levels of excretion of 3-hydroxypropionic acid and methylcitric acid. Patients with propionic acidemia excrete tiglylglycine only when acutely ill or under conditions of poor therapeutic control (1 9), conditions that also cause high levels of excretion of 3-hydroxypropionie acid and methylcitric acid. Propionylglycine has been found in the urine of patients with propionic acidemia (18) . No propionylglycine could be detected in the urine of JR. The excretion of glycine by JR was normal (0.17 mg/mg creatinine). In our experience, the excretion of methylcitric acid in appreciable amounts is the single most reliable index of a defect in the metabolism of propionic acid. The definitive chemical identification of this compound and the precise quantitation of its level of excretion are the contributions of this study and play a significant role in the development of the current level of understanding of this important patient. The metabolic patterns displayed in the urinary organic acids strongly suggested that there was a deficiency of propionyl-CoA carboxylase activity ( 4 , s ) as well as 3-methylcrotonyl-CoA carboxylase activity.
Chalmers et al. (9) have reported the identification by GCMS of 3-hydroxypropionic acid in the urine of JR. These authors also reported the tentative identification of methylcitric acid, although they could not exclude the possibility that the compound was homocitric acid. We have found that the urine of this patient contains no detectable homocitric acid nor does the urine of patients with propionyl-CoA carboxylase deficiency. The urine specimen analyzed by Chalmers et 01. contained very high levels of 3-hydroxybutyric acid, indicating that the patient was markedly ketotic and presumably not recciving biotin. The quantities of metabolites excreted were expressed as gas chromatographic peak areas relative to peak areas of creatinine. Assuming similar response factors, the excretion of 3-hydroxypropionic acid was about half that of 3-hydroxyisovaleric acid and the excretion of methylcitric acid was much greater than that of citric acid. These observations suggest that the activity of propionyl-CoA carboxylase in vivo was quite low at the time the urine was studied.
The excretion of all of the abnormal metabolites (3-hydroxyisovaleric acid, 3-methylcrotonylglycine, 3-hydroxypropionic acid, and methylcitric acid) suggests the possibility of an approach to the rapid prenatal diagnosis of this disorder. We have recently found that methylcitric acid is detectable in the amniotic fluid bathing a fetus with propionyl-CoA carboxylase deficiency (24) . The use of organic acid analysis and gas chromatographymass spectrometry provides an approach to prenatal diagnosis in which direct chemical analysis of the fluid can save the 3-6-week delay required for the growth in culture of cells from amniotic fluid.
The severe ketoacidosis seen in J R before biotin therapy is a characteristic symptom of propionic acidemia (3). It was not seen in the other patients reported with 3-methylcrotonylglycinuria (10, 12, 20) . Thus, it is likely that this aspect of the clinical picture is due not to deficiency of 3-methylcrotonyl-CoA carboxylase but rather to the deficiency of propionyl-CoA carboxylase.
It is now apparent that this patient has a biotin-responsive deficiency of propionyl-CoA carboxylase as well as 3-methylcrotonyl-CoA carboxylase. Bartlett and Gompertz (7) and Weyler et al. (27) have now demonstrated parallel deficiencies of both enzymes in fibroblasts derived from JR. Evidence for the deficiency of two biotin-containing acyl-CoA carboxylases in this patient is consistent with evidence for a biotin-responsive decrease in the excretion of the abnormal metabolities. Together, they strongly suggest that the primary defect is in the metabolism of biotin. Separate primary defects in two carboxylases would be unlikely. Normal activity of both carboxylases has been shown in fibroblasts of this patient when cultured in media containing high concentrations of biotin (7, 27) . Abnormality in the activity of these two enzymes at low concentrations of biotin could represent either a defect in the transport of biotin or a defect in-the enzyme holocarboxylase synthetase (1) that attaches biotin covalentlv to the inactive a~ocarboxvlases to form the enzvmatically active holocarboxylases. Preliminary experiments suggest that a defect in holocarboxylase synthetase is more likely.
C O N C L U S I O N A patient initially described as having biotin-responsive 3-methylcrotonylglycinuria was shown to excrete elevated amounts of 3-hydroxypropionic acid and methylcitric acid, abnormal metabolites found in propionic acidemia, while receiving 0.5 mg biotinlday. This evidence for in vivo deficiency of propionyl-CoA carboxylase activity was confirmed by finding a marked deficiency of propionyl-CoA carboxylase activity in fibroblasts cultured in medium containing low concentrations of biotin.
